Chronic exposure to the divalent heavy metals, lead, manganese (Mn) and chromium, has all been linked to development of severe and irreversible neurological disorders as well as increased risk to develop Parkinson disease. Although the mechanisms by which these metals induce neuronal cell death are not well defined, neurotoxicity is regulated by a number of factors, one of which is the transport of these metals across the blood brain barrier and their subsequent uptake within targeted neuron. Once inside the neuron these heavy metals provoke a series of biochemical and molecular events leading to cell death induced by apoptosis and/or necrosis. In the case of Mn, chronic high level exposure provokes a syndrome resembling Parkinson?s disease, which at the latter stages consists of severe extrapyramidal dysfunction. Recent studies have indicated that Mn toxicity is integrally linked to transport and disposition of iron. Mn is predominantly taken up into cells via the same transporter responsible for iron uptake, i.e. the divalent metal transporter, DMT1. This transporter has a very broad specificity and is responsible for the cellular uptake of other divalent cations as well, including Cd+2, Zn+2, Co+2, Ni+2, Cu+2 and Pb+2. One of the two forms of DMT1, the form containing the iron-response element (+IRE) in the 3?-noncoding region of the message, is negatively regulated by iron status such that if iron levels are low, DMT1 expression is elevated resulting in increased transport and the potential for enhanced metal toxicity. The other form (-IRE) presumably is not regulated in this fashion. Recent studies have demonstrated that the two isoforms of DMT1 (+/-IRE) are distributed in different subcellular compartments with the -IRE species selectively present in the nucleus of neuronal and neuronal-like cells. However, the function and structure of this nuclear-based form of DMT1 have not been determined. Accordingly, we propose to examine the function of both the +IRE and -IRE forms of DMT1 and their contribution to the cellular uptake and subcellular distribution of Mn and their role in supporting heavy metal neurotoxicity. We have a unique ability to study the function of DMT1 in regulating Mn and other heavy metal toxicity since Dr. Michael Garrick, a coinvestigator in this grant, has an animal model, the Belgrade rat, with a mutation in DMT1 making it functionally inactive. Accordingly, the following studies are proposed: 1) determine the contribution of the +/-IRE forms of DMT1 in supporting iron and Mn transport and toxicity, 2) characterize factors regulating expression of +/-IRE forms of DMT1, 3) determine the structural features promoting nuclear localization of the -IRE form of DMT1, 4) determine the function of nuclear DMT1 and its contribution to Mn-induced toxicity, and 5) localization of the +/-IRE isoforms in rat brain.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
1R01ES011127-01A1
Application #
6470013
Study Section
Alcohol and Toxicology Subcommittee 4 (ALTX)
Program Officer
Lawler, Cindy P
Project Start
2002-03-26
Project End
2005-02-28
Budget Start
2002-03-26
Budget End
2003-02-28
Support Year
1
Fiscal Year
2002
Total Cost
$268,577
Indirect Cost
Name
State University of New York at Buffalo
Department
Pharmacology
Type
Schools of Medicine
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Roth, Jerome A; Ganapathy, Balakrishnan; Ghio, Andrew J (2012) Manganese-induced toxicity in normal and human B lymphocyte cell lines containing a homozygous mutation in parkin. Toxicol In Vitro 26:1143-9
Paradkar, Prasad N; Roth, Jerome A (2007) Expression of the 1B isoforms of divalent metal transporter (DMT1) is regulated by interaction of NF-Y with a CCAAT-box element near the transcription start site. J Cell Physiol 211:183-8
Roth, Jerome A (2006) Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination. Biol Res 39:45-57
Garrick, Michael D; Kuo, Hung-Chieh; Vargas, Farida et al. (2006) Comparison of mammalian cell lines expressing distinct isoforms of divalent metal transporter 1 in a tetracycline-regulated fashion. Biochem J 398:539-46
Garrick, Michael D; Singleton, Steven T; Vargas, Farida et al. (2006) DMT1: which metals does it transport? Biol Res 39:79-85
Lis, Agnieszka; Paradkar, Prasad N; Singleton, Steve et al. (2005) Hypoxia induces changes in expression of isoforms of the divalent metal transporter (DMT1) in rat pheochromocytoma (PC12) cells. Biochem Pharmacol 69:1647-55
Lis, Agnieszka; Barone, Tara A; Paradkar, Prasad N et al. (2004) Expression and localization of different forms of DMT1 in normal and tumor astroglial cells. Brain Res Mol Brain Res 122:62-70
Kuo, H C; Smith, J J; Lis, A et al. (2004) Computer-identified nuclear localization signal in exon 1A of the transporter DMT1 is essentially ineffective in nuclear targeting. J Neurosci Res 76:497-511